Introduction
Toxic epidermal necrolysis (TEN) is an acute mucocutaneous drug-induced disease. It is a rare and severe systemic inflammatory condition leading to extensive necrosis and denudation of the skin. In parallel, widespread sloughing of at least two mucosal surfaces is observed, including the oral cavity, gut, genitalia, eyes and bronchioles. Though it is usually a life-threatening condition, nowadays the mortality rate ranges from 8% [unpubl. department data] to 23% [1, 2] , mainly due to sepsis and/or acute visceral failure [3] . Almost all patients surviving an episode of TEN suffer from long-term complications [4] . Among them, cutaneous and ocular sequelae and, to a lesser extent, genitourinary problems and pulmonary disease are noticed [4] [5] [6] .
Clinical and histological analyses of cutaneous longterm complications are rarely described in the literature. We report 2 original cases of a unique presentation of cutaneous sequelae of TEN due to fibrosis and dystrophic calcification.
Case 1
Our first patient was an 18-year-old girl who experienced TEN at the age of 5; no culprit drug was found. She was initially hospitalized for 3 months in a burn center with more than 90% of her body denuded. She received multiple dressings and xenografts covering almost all her body except the face and lower legs. In the acute setting, she temporarily lost her hair, eyebrows, eyelashes and hand nails. She was then referred to our university hospital for the follow-up and management of acute and long-term complications of her condition. Hair and nails were growing again and hypo-and hyperpigmented patches covered the body. She also presented one hypertrophic scar on the arm and multiple hypertrophic papules on the face ( fig. 1 ). She was lost to follow-up for 8 years and then presented for the lesions on her face that had not been fading over time. A 3-mm punch biopsy was performed. Histological analysis showed areas of dermal fibrosis in the dermis in a vertical architecture, with no hair follicles, suggesting scarring hair loss. In addition, small calcifications superficially distributed in the papillary dermis were observed ( fig. 2 ).
Case 2
Our second patient was a 31-year-old man who also had survived a TEN 10 years previously due to oxcarbazepine. He suffered from multiple long-term and disabling sequelae. He had bilateral corneal scarring and neovascularization. His state of almost complete blindness significantly impaired his social and professional life. Multiple hypopigmented papular lesions appeared predominantly on his face after cutaneous healing ( fig. 3 ). Dyspigmentation on the rest of the body and onychodystrophy were also observed. A punch biopsy of one papule on the face showed an image of hypertrophic sebaceous glands in the dermis with a normal epidermis ( fig. 4 ). There were no abnormal dermal fibrosis and no calcification. The cutaneous sequelae on the face that had not been fading over time added to his psychological impairment. Mechanical dermabrasion of the area allowed a slight transient improvement of the clinical appearance of the lesions lasting for a couple of weeks.
Discussion
To our knowledge, fibrosis, cutaneous microcalcification and sebaceous hyperplasia leading to particular facial scars in patients who had survived TEN have never been reported. This permanent peculiar cutaneous presentation, unlike pigmentation disorders usually seen in TEN survivors, has pushed us to perform a biopsy for a better physiopathological understanding.
Magina et al. [7] described the dermatological and ophthalmological sequelae following TEN in 8 surviving patients. The most frequent long-term dermatological complication was dyspigmentation. Other complications reported included de novo alopecia areata, nail dystrophy, geographic tongue and recurrent oral aphthous ulcers. In a recently published 15-year review of pediatric TEN, Quirke et al. [6] found that the most common longterm sequelae were cutaneous such as scarring and changes in skin pigmentation. Other cutaneous long-term com- plications reported in the literature include keloid scars [4] corresponding exactly to the staple sites on which skin substitutes had been applied at the time of the acute illness, onycholysis and onychodystrophy, loss of fingernails, eruptive melanocytic nevi, diffuse thinning of scalp hair and pruritus [4, [8] [9] [10] . A rare case of extensive hypertrophic scarring after TEN is described in a brief report recently published [11] .
Dystrophic calcification can occur as a result of local degenerated or necrotic tissue. It has been observed in burn scars, surgical scars, connective tissue diseases, inherited disorders, infections and trauma [12, 13] . Incidental histological findings of microcalcification have also been detected in cutaneous neoplasms such as trichoepithelioma, basal cell carcinoma, pilomatricoma, fibroma and nevus.
These calcifications are an indication of previous microscopic cell injury. It occurs in areas of cell necrosis in which phosphate-bound denatured proteins are subject to ectopic calcification, promoted by alterations in collagen, elastin and subcutaneous fat [12] . Tissue alterations observed in TEN patients can act like a nidus for dystrophic ectopic calcification. In our first case, we believe that the dermal microcalcifications were secondary to hair follicle destruction with subsequent scarring, as observed in skin biopsy. In a burn wound, hair follicles are permanently lost due to necrosis and ischemia [14] . Interestingly, it is already known that cutaneous adnexa can play a role in the necrolysis process in TEN involving cytotoxic CD8 lymphocytes [15] . We may also speculate that the development of sebaceous hyperplasia could be the result of hair injury, with dystrophic hair follicle reconstitution and a specific postinflammatory healing process. Driskell et al. [16] found that distinct fibroblast lineages are responsible for repairing wounded adult skin: a superficial one that forms the upper dermis including the hair follicles, and a deeper lineage that elaborates the collagenous matrix, the main component of fibrosis. In fact, the cells of the reticular dermis and hypodermis are first activated and generate extracellular matrix and fibrosis lacking hair follicles. Later in the process of re-epithelialization, the superficial fibroblasts become involved. During TEN, necrosis encompasses both the upper and lower dermis. One can imagine that similar repair mechanisms stimulating both superficial and deep fibroblasts, perhaps in a different way, are involved in generating fibrosis and sebaceous hyperplasia.
Furthermore, in our referral center for toxic bullous diseases, we only witnessed this kind of cutaneous scarring in 2 TEN patients. Repair mechanisms in this pediatric population can be noticeably different with a greater capacity of adnexal regeneration. 
Conclusion
Sebaceous hyperplasia, scarring and dystrophic calcifications are distinctive cutaneous complications of TEN. Follicular adnexal necrolysis in the acute phase might be responsible for these complications. Further studies are needed to better understand the physiopathological mechanisms responsible for TEN complications, which could lead to more effective treatment options.
